Results 121 to 130 of about 6,153 (148)

Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome. [PDF]

open access: yesPLoS One
Holcomb NC   +10 more
europepmc   +1 more source

Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years. [PDF]

open access: yesJ Endocr Soc
Terezaki E   +4 more
europepmc   +1 more source

Cancer risk in carriers of TP53 germline variants grouped into different functional categories. [PDF]

open access: yesJNCI Cancer Spectr
Müntnich LJ   +15 more
europepmc   +1 more source

Primary cholangiocarcinoma of the adrenal gland: a surgical and diagnostic challenge - a case report. [PDF]

open access: yesBMC Urol
Nazario-Perez MZ   +5 more
europepmc   +1 more source

EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular Endocrinology.

open access: yesHorm Res Paediatr
Husebye ES   +24 more
europepmc   +1 more source

Pediatric spinal adrenocortical carcinoma

Journal of Pediatric Neuroradiology, 2015
A 5-month-old girl was found on magnetic resonance imaging to have a heterogeneously enhancing conus region mass. At surgery, an extramedullary, intradural mass was resected. Pathology confirmed a diagnosis of adrenocortical carcinoma. The neoplasm originated from ectopic adrenal cortical cell rests in the spine.
Rykken, Jeffrey, Kalina, Peter
openaire   +1 more source

Imaging findings in pediatric adrenocortical carcinoma

Pediatric Radiology, 2000
Adrenocortical carcinoma (ACC), a tumor that is rare among children, causes clinically evident hormonal disturbances. Imaging methods are used to stage disease and to plan surgical resection.To describe the findings of the various imaging methods used to evaluate ACC.We reviewed the records of ten consecutive patients (mean age, 8.1 years) who ...
J, Ribeiro, R C, Ribeiro, B D, Fletcher
openaire   +2 more sources

Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma

Cancer Research, 2023
Abstract Outcomes for pediatric patients with unresectable, metastatic, or relapsed adrenocortical carcinoma (ACC) are dismal despite aggressive management with multimodality therapies. CAR T cell therapy (CAR T) is a promising approach to improve outcomes for patients with this disease.
Rebecca Epperly   +18 more
openaire   +1 more source

Home - About - Disclaimer - Privacy